Abstract |
Chronically elevated glucocorticoids (GCs) and a high-fat diet (HFD) independently induce insulin resistance, abdominal obesity, and nonalcoholic fatty liver disease ( NAFLD). GCs have been linked to increased food intake, particularly energy-dense "comfort" foods. Thus we examined the synergistic actions of GCs and HFD on hepatic disease development in a new rodent model of chronically elevated GCs. Six-week-old male Sprague-Dawley rats received exogenous GCs, via subcutaneous implantation of four 100-mg corticosterone (Cort) pellets, to elevate basal GC levels for 16 days (n = 8-10 per group). Another subset of animals received wax pellets (placebo) to serve as controls. Animals from each group were randomly assigned to receive a 60% HFD or a standard high- carbohydrate (13% fat and 60% carbohydrate) diet. Cort + HFD resulted in central obesity, despite a relative weight loss, a 4-fold increase in hepatic lipid content, hepatic fibrosis, and a 2.8-fold increase in plasma alanine aminotransferase levels compared with placebo + chow controls. Hepatic injury developed independent of inflammation, as plasma haptoglobin levels were reduced with Cort treatment. Insulin resistance and hepatic steatosis occurred with Cort alone; these outcomes were further exacerbated by the HFD in the presence of elevated Cort. In addition to fatty liver, the Cort + HFD group also developed severe insulin resistance, hyperinsulinemia, hyperglycemia, and hypertriglyceridemia, which were not evident with HFD or Cort alone. Thus a HFD dramatically exacerbates the development of NAFLD and characteristics of the metabolic syndrome in conditions of chronically elevated Cort.
|
Authors | Anna M D'souza, Jacqueline L Beaudry, Andrei A Szigiato, Stephen J Trumble, Laelie A Snook, Arend Bonen, Adria Giacca, Michael C Riddell |
Journal | American journal of physiology. Gastrointestinal and liver physiology
(Am J Physiol Gastrointest Liver Physiol)
Vol. 302
Issue 8
Pg. G850-63
(Apr 15 2012)
ISSN: 1522-1547 [Electronic] United States |
PMID | 22268100
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CD36 Antigens
- Ceramides
- Fatty Acids, Nonesterified
- Glucocorticoids
- Protein Kinase C-delta
- Protein Kinase C-epsilon
- Corticosterone
|
Topics |
- Adipose Tissue
(pathology)
- Adrenal Glands
(pathology)
- Animals
- Atrophy
- Blotting, Western
- Body Weight
(physiology)
- CD36 Antigens
(metabolism)
- Cell Membrane
(enzymology)
- Ceramides
(metabolism)
- Circadian Rhythm
(drug effects)
- Corticosterone
(blood, pharmacology)
- Cytosol
(enzymology)
- Diet, High-Fat
(adverse effects)
- Fatty Acids, Nonesterified
(blood)
- Fatty Liver
(chemically induced, pathology)
- Glucocorticoids
(metabolism, pharmacology)
- Insulin Resistance
- Lipid Metabolism
(drug effects)
- Liver
(metabolism, pathology)
- Liver Cirrhosis
(pathology)
- Male
- Muscle, Skeletal
(pathology)
- Portal Vein
(metabolism)
- Protein Kinase C-delta
(metabolism)
- Protein Kinase C-epsilon
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Real-Time Polymerase Chain Reaction
|